Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Microcurrent Stimulation to Treat Macular Degeneration
A completed clinical trial evaluated microcurrent stimulation as a treatment for macular degeneration.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients
A completed clinical trial evaluating whether genetic load influences response to anti-VEGF therapy in Age-related Macular Degeneration.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR) [Phase 3]
This Phase 3 trial compared monthly versus as-needed ranibizumab in patients with subfoveal neovascular age-related macular degeneration, re…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2) [NA]
Update on the completed LUTEGA 2 trial evaluating the long-term effects of lutein, zeaxanthin, and omega-3 supplementation on age-related ma…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration [Phase 1, Phase 2]
Phase 1/2 trial evaluating an ocular sirolimus (rapamycin) formulation for age-related macular degeneration with choroidal neovascularizatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration [Phase 2]
Phase 2 study of ocular sirolimus in combination with Lucentis for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD [Phase 1, Phase 2]
A completed Phase 1/2 prospective trial comparing ranibizumab plus dexamethasone versus ranibizumab monotherapy for wet age-related macular …
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD [Phase 3]
Phase 3 trial evaluating safety and efficacy of Anecortave acetate versus placebo in subfoveal CNV due to exudative age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial update of Anecortave Acetate for subfoveal choroidal neovascularization due to wet age-related macular degeneration; the study…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate Risk-Reduction Trial (AART) [Phase 3]
The Phase 3 Anecortave Acetate Risk-Reduction Trial (AART) for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial of anecortave acetate for exudative age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Anecortave Acetate Risk Reduction Trial (AART) [Phase 3]
Phase 3 trial evaluating anecortave acetate for age-related macular degeneration was terminated.
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMD [NA]
This update documents the completion of a clinical trial evaluating the Implantable Miniature Telescope in patients with age-related macular…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration [Phase 4]
Phase 4 clinical trial update evaluating reduced fluence photodynamic therapy with Visudyne in combination with Lucentis for age-related mac…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Treatment of Age-Related Macular Degeneration With Anecortave Acetate [Phase 2]
A Phase 2 clinical trial evaluating anecortave acetate for age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-24Clinical Trial Update: Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD) [Phase 1]
Phase 1 study evaluating the combination of anecortave acetate and triamcinolone acetonide for exudative age-related macular degeneration ha…
-
CLINICAL_TRIALS trial_result · 2012-10-16Clinical Trial Update: Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy [Phase 1]
A Phase 1 trial of an anti-VEGFR vaccine therapy for neovascular age-related macular degeneration (neovascular maculopathy) has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study). [Phase 2]
Phase II open-label, multicenter trial (MONET) completed comparing PF-04523655 to Lucentis for neovascular age-related macular degeneration …
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD) [Phase 1]
Phase 1 trial update of PF-04523655 (REDD14NP) in patients with choroidal neovascularization secondary to wet age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Combined Therapy in Age-Related Macular Degeneration (ARMD) [Phase 4]
This report notes the completion of a Phase 4 clinical trial evaluating a combined therapy for age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration [Phase 1]
Phase I study of Palomid 529, a dual TORC1/2 inhibitor of the PI3K/Akt/mTOR pathway, for advanced neovascular age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Low Vision Study Comparing EV Training vs. CCTV for AMD Rehabilitation [Phase 2]
Phase 2 trial comparing EV training to CCTV for rehabilitation in age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Safety and Efficacy of Dexamethasone as Adjunctive Therapy to Ranibizumab in Subjects With Choroidal Neovascularization and Age-Related Macular Degeneration [Phase 2]
Phase 2 trial evaluating dexamethasone as adjunctive therapy to ranibizumab for choroidal neovascularization in age-related macular degenera…
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial evaluating an adjunctive therapy to anti-VEGF for wet age-related macular degeneration. The study has completed and results we…
-
CLINICAL_TRIALS trial_result · 2012-09-03Clinical Trial Update: Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial update evaluating a new adjunctive therapy to anti-VEGF for age-related macular degeneration; study completed with results pos…